Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Feb;125(2):311-315.
doi: 10.1097/AOG.0000000000000632.

Increased cervical cancer risk associated with screening at longer intervals

Affiliations
Editorial

Increased cervical cancer risk associated with screening at longer intervals

Walter Kinney et al. Obstet Gynecol. 2015 Feb.

Abstract

The 2012 national recommendations for cervical cancer screening will produce a lower level of cervical cancer protection than previously afforded by annual cytology or 3-year cotesting. After a single negative cotest result, the risk of cervical cancer is twice as large at 5 years as it is at 3 years. Modeling published since the 2012 guidelines were drafted indicates that extending the cotesting screening interval from 3 to 5 years at ages 30-64 years will result in an additional 1 woman in 369 compliant with screening receiving a cervical cancer diagnosis during her lifetime, and an additional 1 in 1,639 dying of cervical cancer. The authors believe that a significant number of patients and providers would not choose to accept these additional risks if they understood them, despite the recognition of potential harms associated with more intensive screening.

PubMed Disclaimer

References

    1. Screening for cervical cancer. Practice Bulletin No. 131. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;120:1222–38.
    1. Dinkelspiel H, Fetterman B, Poitras N, Kinney W, Cox JT, Lorey T, et al.. Cervical cancer rates after the transition from annual pap to 3-year HPV and pap. J Low Genit Tract Dis 2014;18:57–60.
    1. Eddy DM. The frequency of cervical cancer screening. Comparison of a mathematical model with empirical data. Cancer 1987;60:1117–22.
    1. Hutchinson ML, Berger BM, Farber FL. Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity. Am J Manag Care 2000;6:766–80.
    1. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes. Br Med J (Clin Res Ed) 1986;293:659–64.

Publication types

LinkOut - more resources